Document Details
Form
Filing Date
Feb 9, 2022
Document Date
Feb 7, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Neurocrine Biosciences
Issuer
NEUROCRINE BIOSCIENCES INC
Filer
ABERNETHY MATT